comparemela.com

Latest Breaking News On - Marnix van loock - Page 5 : comparemela.com

Johnson & Johnson: Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature

The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans Findings support further clinical development for prevention and treatment of dengue, which impacts millions

United statesBaden wübergDennis riedlRuxandra draghia akliMarnix van loockTesia williamsTrish garrityWalter reed army institute of researchJanssen research developmentJanssen pharmaceutical companiesJanssen pharmaceutical companies of johnsonGlobal health discovery atMarseille universityDepartment of infectious diseases at heidelberg universityUniversity of texas medical branch healthNone of the janssen pharmaceutical companies

Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nat

The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humansFindings support further clinical development for prevention and treatment of dengue, which impacts millions of people today and is poised to threaten many more due to climate changeResearch builds on Johnson & Johnson’s endu.

United statesMarnix van loockRuxandra draghia akliTesia williamsTrish garrityWalter reed army institute of researchJanssen research developmentJanssen pharmaceutical companiesJanssen pharmaceutical companies of johnsonGlobal health discovery atMarseille universityDepartment of infectious diseases at heidelberg universityUniversity of texas medical branch healthNone of the janssen pharmaceutical companiesBiomedical primate research centreGlobal public health

Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Pacific at Duke-NUS to Advance Dengue Research

/PRNewswire/ Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of the new J&J Satellite Center for Global Health Discovery (Satellite.

Cape townWestern capeSouth africaUniversity of cape townNational university of singaporeSingapore generalMarnix van loockRuxandra draghia akliSubhash vasudevanPatrick caseyOlivia goethalsAsia pacificPrnewswire johnsonGlobal health discovery quickfireJanssen biotech incCfd centre

Researchers identify first drug that is effective against dengue infection

Belgium: A recent study reported in the journal Nature has described a new target for the treatment of dengue. The antiviral compound showed strong activity in mice for prophylaxis against dengue and.

Region flamandeUnited statesMarnix van loockJannsen pharmaceuticaJanssen pharmaceuticaJanssen global public healthKu leuven rega instituteRega instituteDrug designDengue drugDengue treatmentDengue virus infection

KU Leuven develops very potent antiviral against dengue

Researchers at the KU Leuven Rega Institute and CD3 have developed an ultrapotent inhibitor of the dengue virus, which causes the tropical disease known as dengue. The teams collaborated closely with Janssen Pharmaceutica, N.V. The antiviral molecule is exceptionally effective against all known dengue variants and could be used for therapeutic and prevention purposes. The teams have published their findings in Nature.

United statesJohan neyts ku leuvenMarnix van loockJohan neytsOlivia goethalsPatrick chaltinTim jonckersJanssen pharmaceuticaRob stevensRalf bartenschlagerRega instituteWorld health organizationJohan neyts rega instituteCentre for drug designMarseille universityKu leuven rega institute

vimarsana © 2020. All Rights Reserved.